Evolus EBIT 2016-2025 | EOLS

Evolus ebit from 2016 to 2025. Ebit can be defined as earnings before interest and taxes.

Evolus EBIT 2016-2025 | EOLS

Evolus ebit from 2016 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$226.1B
Boston Scientific (BSX)$158.2B
Stryker (SYK)$145.8B
EssilorLuxottica (ESLOY)$137.4B
Medtronic (MDT)$115B
Lonza Group Ag (LZAGY)$49.3B
ResMed (RMD)$42.7B
Haleon (HLN)$42.7B
Agilent Technologies (A)$32.6B
GE HealthCare Technologies (GEHC)$32.3B
Koninklijke Philips (PHG)$25.7B
Terumo (TRUMY)$25.7B
Insulet (PODD)$20.3B
Zimmer Biomet Holdings (ZBH)$18.3B
Smith & Nephew SNATS (SNN)$13.5B
Baxter (BAX)$11.5B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.5B
Lantheus Holdings (LNTH)$4.9B
Perrigo (PRGO)$3.7B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.7B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.8B
QuidelOrtho (QDEL)$1.6B
Green Thumb Industries (GTBIF)$1.5B